Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_assertion description "[Dysregulation of cyclin-dependent kinase 4 (CDK4) and CDK6 by gain of function or loss of inhibition is common in human cancer, including multiple myeloma, but success in targeting CDK with broad-spectrum inhibitors has been modest.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_assertion evidence source_evidence_literature NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_assertion SIO_000772 22718837 NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_assertion wasDerivedFrom befree-20150227 NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_assertion wasGeneratedBy ECO_0000203 NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP301626.RATF1Vli5htSEZOrw876U6_1NwqFcnex2Mh1_BXnBGob8130_provenance.